Disability

TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial

Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis

Majority of patients met the American College of Rheumatology improvement criteria (ACR70) response by Week 36 Single-dose of miv-cel delivered...

Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis

Majority of patients met the American College of Rheumatology improvement criteria (ACR70) response by Week 36 Single-dose of miv-cel delivered...

TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)

Pharmacokinetic and pharmacodynamic data support quarterly subcutaneous BRIUMVI dosing regimen currently under evaluation in fully enrolled Phase 3 trial; Top-line...

From Fusion to Motion: Dr. Joel S. Beckett Presented Restorative Motion Surgery Concepts at the Hoag Orthopedic Institute Spine Symposium

Presentation explored motion-restoring alternatives for select patients with persistent pain or pseudoarthrosis following cervical fusion surgery BEVERLY HILLS, CA /...

Siemens Healthineers and Cercare Medical Announce Global Collaboration on Cone-Beam CT Perfusion Guided Stroke Treatment

Cone-Beam Computed Tomography Perfusion allows for more insights to support clear diagnosis and precise treatment of stroke patientsCollaboration supports the...

Siemens Healthineers and Cercare Medical Announce Global Collaboration on Cone-Beam CT Perfusion Guided Stroke Treatment

Cone-Beam Computed Tomography Perfusion allows for more insights to support clear diagnosis and precise treatment of stroke patientsCollaboration supports the...

Empirical Spine Announces First Commercial LimiFlex(R) Cases at Stanford Medicine, Marking U.S. Launch of Motion-Preserving Alternative to Fusion for Degenerative Spondylolisthesis

First U.S. commercial cases establish LimiFlex as an outpatient, motion-preserving stabilization option SAN CARLOS, CA / ACCESS Newswire / May...

Empirical Spine Announces First Commercial LimiFlex(R) Cases at Stanford Medicine, Marking U.S. Launch of Motion-Preserving Alternative to Fusion for Degenerative Spondylolisthesis

First U.S. commercial cases establish LimiFlex as an outpatient, motion-preserving stabilization option SAN CARLOS, CA / ACCESS Newswire / May...

error: Content is protected !!